Alkem Laboratories Ltd - 539523 - Shareholding for the Period Ended March 31, 2021
Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here20-04-2021
20-04-2021
Alkem Laboratories Ltd - 539523 - Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance officer and the authorised representative of Link Intime India Pvt Ltd (RTA) for the half year ended 31st March, 2021. Kindly take the same on your records.12-04-2021
Alkem Laboratories Ltd - 539523 - Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half Year Ended 31St March, 2021.
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the half year ended 31st March, 2021. Kindly take the same on record.12-04-2021
Alkem Laboratories Ltd - 539523 - Statement Of Investor Complaints For The Quarter Ended March 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Mr Manish NarangDesignation :- Company Secretary and Compliance Officer09-04-2021
Alkem Laboratories Ltd - 539523 - Disclosure Under Regulation 30 Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ('SEBI Listing Regulations')
This is to inform you that the Board of Directors of the Company approved the commencement of commercial production/ operations at the Chakan manufacturing facility of Enzene Biosciences Limited (subsidiary of the Company) situated at A-22, A/1/2, Chakan Industrial Area, Phase-2, Khalumbre, Chakan, Pune 410501, Maharashtra, India w.e.f. today, i.e. 09th April, 2021. Kindly take the same on record.09-04-2021
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We refer to our disclosure, dated 01st April, 2021, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 informing interalia that DigiHealth Technologies LLP, (the wholly owned entity of our investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP)), has agreed to acquire 100% ownership interest in Pharmarack Technologies Private Limited ('Pharmarack') in tranches. Further to the above, we wish to inform you that the above-referred entity, DigiHealth Technologies LLP has completed on 05th April, 2021 the acquisition of 91.8% of shareholding in Pharmarack by purchase of shares from multiple shareholders in various lots. This is for your information and dissemination.06-04-2021
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We would like to inform you that DigiHealth Technologies LLP, the wholly owned entity of our Indian investee entity i.e. ABCD Technologies LLP (to be renamed as IndoHealth Services LLP), has agreed to acquire 100% ownership interest in Pharmarack Technologies Private Limited in tranches. The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular No. CIR/CFO/CMD/4/2015 dated 9th September, 2015, are enclosed herewith. We request you to kindly take this in your record and disseminate.01-04-2021
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
We would like to inform you that our investee company i.e. ABCD Technologies LLP (to be renamed as IndoHealth Technologies LLP) has through its wholly-owned entity DigiHealth Services LLP, acquired 66.02% ownership interest in AIOCD Pharmasofttech Awacs Private Limited ('AWACS'). The details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Circular No. CIR/CFO/CMD/4/2015 dated 9th September, 2015 are enclosed herewith. We request you to kindly take this in your record and disseminate.31-03-2021
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisition
This is to inform you that Alkem Laboratories Limited has agreed in principle to subscribe to a partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth services LLP). The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Clause A(l) of Part A, Schedule III of the aforesaid Regulations, is attached as per ''Annexure A". This is for your information and record.30-03-2021
Alkem Laboratories Ltd - 539523 - Closure of Trading Window
This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th March, 2021 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and year ended 31st March, 2021 are communicated to the Stock Exchanges.26-03-2021